Finland · research
Finland · researchValo Therapeutics
Valo Therapeutics is an immunooncology company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines.
PrivateFor profit
Against its peers
Set against 3,254 research companies worldwide. The ring marks the typical peer.
Across all 5.9M companies: larger than 33% of those with a size listed; older than 5% of those with a founding year; website ranked #7,371,142 in the world, about 800 visits a month.
About Valo Therapeutics
BiotechnologyHealth CareMedicalOncologyTherapeutics
Funding, as listed
What the source datasets report. We have not watched these rounds ourselves.
$21M
raised in total, currency not stated across 4 rounds
Last raised Feb 2023, 3 years ago
- Rounds
- 4
- Latest round
- Grant
- Investors
- 22 leading
Key facts
Who started it and how it trades.
- Founded by
- Vincenzo Cerullo
Every detail we hold
Everything the source datasets list about Valo Therapeutics, field by field. Contact details are held but never shown.
The company7 fields
- Name
- Valo Therapeutics
- Type
- For profit
- Status
- Private
- Founded
- 2016
- Founders
- Vincenzo Cerullo
- Industry
- research
- Categories
- Biotechnology, Health Care, Medical, Oncology, Therapeutics
Where3 fields
- City
- Helsinki
- Country
- Finland
- Markets
- European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA)
Size and reach3 fields
- Staff band
- 11-50
- Web traffic rank
- #7,371,142
- Monthly web visits
- 800
Show 9 more fieldsShow fewer fields
Funding, as listed7 fields
- Total
- 20,554,162 (currency not stated)
- Rounds
- 4
- Latest round
- Grant
- Latest round date
- Feb 2023
- Investors
- 2
- Lead investors
- 2
- Listing status
- private
About this record2 fields
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Valo Therapeutics may be growing as it is mentioned alongside other companies in the context of the biotechnology industry, indicating its relevance in the sector. The company is listed in a briefing that discusses the growing importance of technologies in immuno-oncology, suggesting that it is part of an innovative and expanding field. Additionally, the mention of '35' alongside the company's name could imply a ranking or a metric that signifies the company's presence and activity within the industry.
Companies like Valo Therapeutics
research in Finland.
VolareHelsinki · 1-10 peoplefounded 5 years later
AlgorithmiqMilano · 11-50 peoplefounded 4 years later
Linio Biotech LtdHelsinki · 11-50 peoplefounded 1 years later
Rappta TherapeuticsHelsingfors · 11-50 peoplefounded 10 years earlier
FIT BiotechTampere · 11-50 peoplefounded 21 years earlier
MeasurlabsHelsinki · 11-50 peoplefounded 1 years laterBuild a lead list
Every research company, filtered by size, age and reach, ready to export with emails on Pro.